Patients with breast cancer had a lower overall survival rate when certain genes, including CD19, CD79A, CD83, XCL1, BIRC3, BTLA, FCRLA, MS4A1, SPIB, TCL1A, and IGF2R, are expressed at different levels (Fig. 6B). This evidence concerns the gene BIRC3 and breast carcinoma.